
Tunable Bonds: A Step Towards Targeted At-211 Cancer Therapy
Scientists can tune the strength of astatine-211 bonds with chemicals called ketones, laying the groundwork for a new class of radiopharmaceuticals.
Scientists can tune the strength of astatine-211 bonds with chemicals called ketones, laying the groundwork for a new class of radiopharmaceuticals.
A newly proposed approach aids chemical studies of rare, toxic, radioactive, and precious isotopes by requiring 1,000 times less material.
This new method individually separates heavy metals — an actinide chemist’s dream.
High-energy proton experiments optimize production of medical imaging isotopes while providing insight into how to protect astronauts from space radiation.
University researchers produce a novel method of shipping the promising medical isotope Astatine-211
NextGen power sources may satisfy the need for long-term, compact power for use in remote or extreme environments.
Promising study details how radioactive agents could be sent directly to cancer cells.
New production methods for cerium-134 advance technologies for imaging human disease and guiding treatment.
A high-speed, high-yield recovery approach for At-211 means improved availability of this cancer-treating isotope.
New system makes it easier to produce isotopes for radiopharmaceutical therapy.
A new supply of a critical radioisotope advances personalized medicine.
Innovative technology improves isotope production yields and enhances capabilities for advanced research on new isotopes for medical applications.